The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation

Summary

The aim of this prospective randomized double-blind study was to compare the efficacy of new pharmaceutical composition containing botulinum toxin injection in epicardial fat pads for preventing recurrences of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation undergoing coronary artery bypass grafting.

Timeline

Start

2016-09

Primary completion

2017-12

Completion

2018-02

Drugs

Indications